Skip to content

Clinical trials

Phase 3 COVID-19 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: United States Clear all

166 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20181
20191
202079
202142
202217
20239
20245
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated37
Recruiting11
Unknown status9
Withdrawn7
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
BioNTech SE10
Susanna Naggie, MD8
University of Minnesota6
AstraZeneca5
Gilead Sciences5
Novavax5
Larkin Community Hospital4
ModernaTX, Inc.4
Pfizer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19166
Coronavirus Infections47
Severe Acute Respiratory Syndrome25
Virus Diseases20
RNA Virus Infections15
Coronaviridae Infections14
Nidovirales Infections13
Pneumonia13
Lung Diseases7
Pneumonia, Viral7

Trials

Showing 1 to 25 of 166. Each trial links to its page on Pharma Observatory.

66 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.